Evidence map›Paper›PMID 39296216›Full record

ArticleHeliyon2024

Development and characterization of a zeolite based drug delivery system: Application to cannabidiol oral delivery.

Fouad Dernaika, Layal Halawy, Joseph Zeaiter, Sara Kawrani, Dima Mroue, Anthony Lteif, Sima Kourani, Mohamed Mehanna, Celine Abboud, Mohamad Mroueh and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Novel Organomineral Complex with Prolonged Antitumor Action.International journal of molecular sciences · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fouad DernaikaDepartment of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Layal HalawyBahaa and Walid Bassatne Department of Chemical Engineering and Advanced Energy, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Lebanon.
Joseph ZeaiterBahaa and Walid Bassatne Department of Chemical Engineering and Advanced Energy, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Lebanon.
Sara KawraniDepartment of Natural Sciences, School of Art and Sciences, Lebanese American University, Byblos, Lebanon.
Dima MroueDepartment of Natural Sciences, School of Art and Sciences, Lebanese American University, Byblos, Lebanon.
Anthony LteifDepartment of Natural Sciences, School of Art and Sciences, Lebanese American University, Byblos, Lebanon.
Sima KouraniDepartment of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Mohamed MehannaDepartment of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Celine AbboudDepartment of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Mohamad MrouehDepartment of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Aline MilaneDepartment of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing interest in the therapeutic potential of cannabidiol (CBD) has led to the need for effective and reliable delivery methods that overcome its low oral absorption. Zeolites, a class of porous nanoparticles, offer unique advantages as drug carriers due to their high surface area and adjustable pore size. In this study, a zeolite-based drug delivery system was developed for the encapsulation of CBD. The zeolite particles were characterized using various techniques such as Scanning Electron Microscopy (SEM), N

Indexed as

CannabidiolDrug deliveryDrug releaseIn-vitro dissolutionZeolites

Identifiers

PMID39296216
PMCPMC11409077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.